Jack Geduldig

4PUBLICATIONS
46CO-AUTHORS
Radiation therapyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 23, 2025
Immunotherapy-based neoadjuvant treatment and complication rates after radical cystectomy.

Reuben Ben-David, Francesco Pellegrino, Reza Mehrazin

|Oct 16, 2024
Undetectable pre-radical cystectomy circulating tumour DNA status predicts improved oncological outcomes.

Reuben Ben-David, Sarah Lidagoster, Jack Geduldig

|Sep 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization.

Rifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee

|May 15, 2023
Outcomes from a prospectively implemented protocol using apixaban after robot-assisted radical cystectomy.

Jordan M Rich, Yuval Elkun, Jack Geduldig

Pageof 1

Frequent Collaborators

2 joint publications

Reza Mehrazin

2 joint publications

Peter Wiklund

2 joint publications

Kyrollis Attalla

2 joint publications

John P Sfakianos